Todd Meadow is a Director in the Financial Sponsors group, covering a broad range of large cap, cross cap and middle market private equity funds and other alternative asset managers. Todd joined Lazard in 2018 as a Vice President in the Capital Markets Advisory group.
Todd's experience at Lazard also includes a number of high-profile strategic M&A and capital markets engagements, including advising Teladoc Health on its acquisition of Livongo Health, and the unwind of a capped call on $550mm of Livongo Health Convertible Senior Notes; advising Versum Materials on its sale to Merck KGaA subsequent to the proposed merger of equals transaction with Entegris and hostile defense from Merck KGaA; guiding the Special Committee of Papa John's International in its interaction with its founder and the eventual convertible-preferred investment from Starboard Value.
Prior to joining Lazard, Todd was a Vice President and Senior Credit Analyst at Nomura Securities, where he was responsible for identifying and managing credit and equity-linked principal investments on the firm's behalf. While at Nomura, Todd led the underwriting of a $125M PIPE commitment to Hennessy Capital Acquisition Corp (SPAC) in its acquisition of NRC Group Holdings, LLC, from affiliates of J.F. Lehman.
Prior to Nomura, Todd was an Associate at Goldman Sachs Asset Management, where he was an analyst for the Liberty Harbor hedge fund, specializing in public and private credit and equity-linked investments. Prior to Goldman Sachs, Todd was an analyst in the Global Investment Group at Amaranth Advisors.
Todd began his career as a corporate attorney with King & Spalding, where he advised clients on M&A, leveraged buyouts, bankruptcy restructurings, securities offerings and corporate governance matters.
Todd earned a B.S. in Integrated Business and Engineering (IBE) from Lehigh University and a J.D. with honors from the University of Connecticut School of Law, where he was an editor of the Connecticut Law Review. Todd is admitted to the bar in New York and Connecticut.